Inactivation of Plasmodium falciparum by photodynamic excitation of heme-cyde intermediates derived from δ-aminolevulinic acid

Journal of Infectious Diseases

Volumn 190, Issue 1, 2004, Pages 184-191

  Smith, Todd G ^a,d   Kain, Kevin C ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d ACADIA UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; HEME; LACTATE DEHYDROGENASE;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ASSAY; ERYTHROCYTE; FLUORESCENCE MICROSCOPY; LIGHT EXPOSURE; MICROSCOPY; NONHUMAN; PHOTOACTIVATION; PHOTODYNAMICS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

AMINOLEVULINIC ACID; ANIMALS; CULTURE MEDIA; ERYTHROCYTES; HEME; HUMANS; LIGHT; MICROSCOPY, FLUORESCENCE; PARASITOLOGY; PHOTOSENSITIZING AGENTS; PLASMODIUM FALCIPARUM;

EID: 3042803773     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/421503     Document Type: Article

References (68)

1. Sachs J, Malaney P. The economic and social burden of malaria. Nature 2002; 415:680-5.
2. Greenwood B, Mutabingwa T. Malaria in 2002. Nature 2002; 415:670-2.
3. Slinger R, Giulivi A, Bodie-Collins M, et al. Transfusion-transmitted malaria in Canada. CMAJ 2001; 164:377-9.
4. Mungai M, Tegtmeier G, Chamberland M, Parise M. Transfusion-transmitted malaria in the United States from 1963-1999. New Engl J Med 2001; 344:1973-8.
5. Sato S, Wilson RJM. The genome of Plasmodium falciparum encodes an active δ-aminolevulinic acid dehydratase. Curr Genet 2002; 40:391-8.
6. Padmanaban G, Rangarajan PN. Heme metabolism of Plasmodium is a major antimalarial target. Biochem Biophys Res Commun 2000; 268:665-8.
7. Moan J, Van den Akker JTHM, Juzenas P, et al. On the basis for tumour selectivity in the 5-aminolevulinic acid-induced synthesis of protoporphyrin IX. J Porphyrins Phthalocyanines 2001; 5:170-6.
8. Aldritt SM, Joseph JT, Wirth DF. Sequence identification of cytochrome b in Plasmodium falciparum. Mol Cell Biol 1989; 9:3614-20.
9. Fry M, Beesley JE. Mitochondria of mammalian Plasmodium spp. Parasitology 1991; 102:17-26.
10. Rosenthal PJ, Meshnick SR. Hemoglobin processing and the metabolism of amino acids, heme, and iron. In: Sherman IW, ed. Malaria: parasite biology, pathogenesis and protection, Washington: ASM Press, 1998:145-58.
11. Surolia N, Padmanaban G. De novo synthesis of heme offers a new chemotherapeutic target in the human malaria parasite. Biochem Biophys Res Commun 1992; 187:744-50.
12. Goldie P, Roth EF, Oppenheim J, Vanderberg JP. Biochemical characterization of Plasmodium falciparum hemozoin. Am J Trop Med Hyg 1990; 43:584-96.
13. Sullivan DJ, Gluzman IY, Goldberg DE. Plasmodium hemozoin formation mediated by histidine-rich proteins. Science 1996; 271:219-22.
14. Wilson CW, Smith AB, Baylon RV. Characterization of the delta-aminolevulinate synthase gene homologue in P. falciparum. Mol Biochem Parasitol 1996; 75:271-6.
15. Bonday ZQ, Taketani S, Gupta PD, Padmanaban G. Heme biosynthesis by the malaria parasite. J Biol Chem 1997; 272:21839-46.
16. Pouvelle B, Spiegel R, Hsiao L, et al. Direct access to serum macromolecules by intraerythrocytic malaria parasites. Nature 1991; 353:73-5.
17. Lauer SA, Rathod PK, Ghori N, Haldar K. A membrane network for nutrient import in red cells infected with the malaria parasite. Science 1997; 276:1122-5.
18. Divaris DXG, Kennedy JC, Pottier RH. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol 1990; 136:891-7.
19. Iinuma S, Farshi SS, Ortel B, Hasan T. A mechanistic study of cellular photodestruction with 5-aminolevulinic acid-induced porphyrin. Br J Cancer 1994; 70:21-8.
20. Tabata K, Ogura S, Okura I. Photodynamic efficiency of protoporphyrin IX: comparison of endogenous protoporphyrin IX induced by 5-aminolevulinic acid and exogenous porphyrin IX. Photochem Photobiol 1997; 66:842-6.
21. Wilson BC, Olivo M, Singh G. Subcellular localization of Photfrin and aminolevulinic acid and photodynamic cross-resistance in vitro in radiation-induced fibrosarcoma cells sensitive or resistant to Photfrin-mediated photodynamic therapy. Photochem Photobiol 1997; 65:166-76.
22. Barr H, Dix AJ, Kendall C, Stone N. The potential role for photodynamic therapy in the management of upper gastrointestinal disease. Aliment Pharmacol Ther 2001; 15:311-21.
23. Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KH, Boyle D, Mittleman A. Photoradiation therapy for the treatment of malignant tumours. Cancer Res 1978; 38:2628-35.
24. De Rosa FS, Bentley MVLB. Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives. Pharm Res 2000; 17:1447-55.
25. Walliker D, Quakyi IA, Wellems TE, et al. Genetic analysis of the human malaria parasite Plasmodium falciparum. Science 1987; 236:1661-6.
26. Roberts DJ, Craig AF, Berendt AR, et al. Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 1992; 357:689-92.
27. Trager W, Jensen JB. Human malaria parasites in continuous culture. Science 1976; 193:673-7.
28. Smith TG, Lourenco P, Carter R, Walliker D, Ranford-Cartwright LC. Commitment to sexual differentiation in the human malaria parasite, Plasmodium falciparum. Parasitology 2000; 121:127-33.
29. Gadmar OB, Moan J, Scheie E, Ma LW, Peng Q. The stability of 5-aminolevulinic acid in solution. J Photochem Photobiol B 2002; 67:187-93.
30. Grebenova D, Cajthamlova H, Bartosova J, et al. Selective destruction of leukaemic cells by photo-activation of 5-aminolevulinic acid-induced protoporphyrin-IX. J Photochem Photobiol B 1998; 47:74-81.
31. Makler MT, Hinrichs DJ. Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. Am J Trop Med Hyg 1993; 48:205-10.
32. Makler MT, Ries JM, Williams JA. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am J Trop Med Hyg 1993; 48:739-41.
33. Chitnis CE, Blackman MJ. Host cell invasion by malaria parasites. Parasitol Today 2000; 16:411-5.
34. Pinder JC, Fowler RE, Bannister LH, Dluzewski AR, Mitchell GH. Motile systems in malaria merozoites: how is the red blood cell invaded? Parasitol Today 2000; 16:240-5.
35. Gardner MJ, Hall N, Fung E, et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002; 419:498-511.
36. Varadharajan S, Dhanasekaran S, Bonday ZQ, Rangarajan PN, Padmanaban G. Involvement of δ-aminolaevulinate synthase encoded by the parasite gene in de novo haem synthesis by Plasmodium falciparum. Biochem J 2002; 367:321-7.
37. Bonday ZQ, Dhanasekaran S, Rangarajan PN, Padmanaban G. Import of host δ-aminolevulinate dehydratase into the malarial parasite: identification of a new drug target. Nature Med 2000; 6:898-903.
38. Van Dooren FF, Su V, D'Ombrain MC, McFadden GI. Processing of an apicoplast leader sequence in Plasmodium falciparum and the identification of a putative leader cleavage enzyme. J Biol Chem 2002; 277:23612-9.
39. Wilson RJM. Progress with parasite plastids. J Mol Biol 2002; 319:257-74.
40. Waller RF, Keeling RP, Donald RG, et al. Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum. Proc Natl Acad Sci USA 1998; 95:12352-7.
41. Waller RF, Reed MB, Cowman AF, McFadden GI. Protein trafficking to the plastid of Plasmodium falciparum is via the secretory pathway. EMBO J 2000; 19:1794-802.
42. Hopkins J, Fowler R, Krishna S, Wilson I, Mitchell G, Bannister L. The plastid in Plasmodium falciparum asexual blood stages: a three-dimensional ultrastructural analysis. Protist 1999; 150:283-95.
43. Smith OM, Dolan SA, Dvorak JA, Wellems TE, Sieber F. Merocyanine 540-sensitized photoinactivation of human erythrocytes parasitized with Plasmodium falciparum. Blood 1992; 80:21-4.
44. Lagerberg JWM, Williams M, Moor ACE, et al. The influence of merocyanine 540 and protoporphyrin on physicochemical properties of the erythrocyte membrane. Biochim Biophys Acta 1996; 1278:247-53.
45. Lagerberg JWM, VanSteveninck J, Dubbelman TMAR. Effect of membrane potential on the binding of merocyanine 540 to human erythrocytes. Photochem Photobiol 1998; 67:729-33.
46. Lagerberg JWM, Uberriegler KP, Krammer B, VanSteveninck J, Dubbelman TMAR. Plasma membrane properties involved in the photodynamic efficacy of merocyanine 540 and tetrasulfonated aluminum phthalocyanine. Photochem Photobiol 2000; 71:341-6.
47. Sikurova L, Cabanik A, Ruttkay-Nedecky G. Peroxidation damage of erythrocyte membranes by merocyanine 540. Pharmazie 2001; 56:974-5.
48. Grellier P, Santus R, Mouray E, et al. Photosensitized inactivation of Plasmodium falciparum and Babesia divergens-infected erythrocytes in whole blood by lipophilic pheophorbide derivatives. Vox Sang 1997; 72:211-20.
49. Lustigman S, BenHur E. Photosensitized inactivation of Plasmodium falciparum in human red cells by phthalocyanines. Transfusion 1996; 36:543-6.
50. Zhao XJ, Lustigman S, Kenney ME, BenHur E. Structure-activity and mechanism studies on silicon phthalocyanines with Plasmodium falciparum in the dark and under red light. Photochem Photobiol 1997; 66:282-7.
51. Akompong T, Ghori N, Haldar K. In vitro activity of riboflavin against the human malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother 2000; 44:88-96.
52. Akompong T, Eksi S, Williamson K, Haldar K. Gametocytocidal activity and synergistic interaction of riboflavin with standard antimalarial drugs against growth of Plasmodium falciparum in vitro. Antimicrob Agents Chemother 2000; 44:3107-11.
53. Goodrich RP. The use of riboflavin for the interaction of pathogens in blood products. Vox Sang 2000; 78 (Suppl 2):211-5.
54. Lin L, Cook DN, Wiesehahn GP, et al. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion 1997; 37:423-35.
55. Wollowitz S. Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma. Semin Hematol 2001; 38 (Suppl):4-11.
56. Corash L. Inactivation of infectious pathogens in labile blood components: meeting the challenge. Transfus Clin Biol 2001; 8:138-45.
57. Dodd RY. Pathogen inactivation: mechanisms of action and in vitro efficacy of various agents. Vox Sang 2002; 83 (Suppl 1):267-70.
58. AuBuchon JP. Pathogen inactivation in cellular blood components: Clinical trials and implications of introduction to transfusion medicine. Vox Sang 2002; 83 (Suppl 1):271-5.
59. Purmal A, Valeri DR, Dzik W, et al. Process for the preparation of pathogen-inactivated RBC concentrates by using PEN110 chemistry: preclinical studies. Transfusion 2002; 42:139-45.
60. Fritsch C, Verwohlt B, Bolsen K, Ruzicka T, Goerz G. Influence of topical photodynamic therapy with 5-aminolevulinic acid on porphyrin metabolism. Arch Dermatol Res 1996; 288:517-21.
61. Killig F, Kunz L, Stark G. Photomodification of the electrical properties of the plasma membrane: a comparison between 6 different membrane-active photosensitisers. J Membr Biol 2001; 181:41-6.
62. Pottier RH, Chow YFA, LaPlante J-P, Truscott TG, Kennedy JC, Beiner LA. Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo. Photochem Photobiol 1986; 44:679-87.
63. Fuchs J, Weber S, Kaufmann R. Genotoxic potential of porphyrin type photosensitizers with particular emphasis on 5-aminolevulinic acid: implications for clinical photodynamic therapy. Free Radic Biol Med 2000; 28:537-48.
64. Karbownik M, Tan DX, Reiter RJ. Melatonin reduces the oxidation of nuclear DNA and membrane lipids induced by the carcinogen delta-aminolevulinic acid. Int J Cancer 2000; 88:7-11.
65. Kain KC, Bu Jassoum S, Fong IW, Hannach B. Transfusion-transmitted babesiosis in Ontario: first reported case in Canada. CMAJ 2001; 164:1721-3.
66. Gaughan PLZ, Klassner SM. Hemin deprivation in culture stages of the hemoflagellate, Leishmania tarentolae. Comp Biochem Physiol 1971; 39:5-18.
67. Salzman TA, Stella AM, Wider DeXifra EA, et al. Porphyrin biosynthesis in parasitic hemoflagellates: functional and defective enzymes in Trypanosoma cruzi. Comp Biochem Physiol B 1982; 72:663-7.
68. Srivastava P, Sharma GD, Kamboj KK, Rastogi AK, Pandey VC. Heme metabolism in promastigotes of Leishmania donovani. Mol Cell Biochem 1997; 171:65-8.